{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:02:46Z","timestamp":1790301766780,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21AI155842"],"award-info":[{"award-number":["1R21AI155842"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015158","name":"Fondren Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015158","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ajpath.2022.06.011","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T02:07:35Z","timestamp":1657850855000},"page":"1397-1406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Chimeric Penicillin Binding Protein 2X Significantly Decreases in\u00a0Vitro Beta-Lactam Susceptibility and Increases in\u00a0Vivo Fitness of Streptococcus pyogenes"],"prefix":"10.1016","volume":"192","author":[{"given":"Randall J.","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luchang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regan E.","family":"Mangham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Faili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Kayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Beres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Musser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2022.06.011_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajpath.2022.06.011_bib2","first-page":"1","article-title":"Group A streptococcal diseases and their global burden","volume":"368","author":"Ralph","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ajpath.2022.06.011_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM200101183440308","article-title":"Acute pharyngitis","volume":"344","author":"Bisno","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2022.06.011_bib4","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1056\/NEJMra1600673","article-title":"Necrotizing soft-tissue infections","volume":"377","author":"Stevens","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2022.06.011_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of Group A Streptococcus","volume":"27","author":"Walker","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ajpath.2022.06.011_bib6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJMcp1009126","article-title":"Clinical practice. Streptococcal pharyngitis","volume":"364","author":"Wessels","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2022.06.011_bib7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2022.06.011_bib8","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1016\/j.vaccine.2018.02.068","article-title":"WHO\/IVI global stakeholder consultation on Group A Streptococcus vaccine development: report from a meeting held on 12-13 December 2016","volume":"36","author":"Osowicki","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ajpath.2022.06.011_bib9","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.vaccine.2017.02.060","article-title":"Clinical development strategy for a candidate group A streptococcal vaccine","volume":"35","author":"Sch\u00f6del","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ajpath.2022.06.011_bib10","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.vaccine.2016.03.073","article-title":"Status of research and development of vaccines for Streptococcus pyogenes","volume":"34","author":"Steer","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ajpath.2022.06.011_bib11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciy1143","article-title":"The path to group A streptococcus vaccines: World Health Organization research and development technology roadmap and preferred product characteristics","volume":"69","author":"Vekemans","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2022.06.011_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/cid\/ciab852","article-title":"Association of pneumococcal serotype with susceptibility to antimicrobial drugs: a systematic review and meta-analysis","volume":"75","author":"Andrejko","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2022.06.011_bib13","doi-asserted-by":"crossref","first-page":"iv39","DOI":"10.1093\/jac\/dkz286","article-title":"Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16","volume":"74","author":"Golden","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajpath.2022.06.011_bib14","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1093\/jac\/dkw320","article-title":"Description and characterization of a penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis clone isolated from blood in three epidemiologically linked patients","volume":"71","author":"Fuursted","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajpath.2022.06.011_bib15","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/AAC.00185-08","article-title":"First molecular characterization of group B streptococci with reduced penicillin susceptibility","volume":"52","author":"Kimura","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajpath.2022.06.011_bib16","doi-asserted-by":"crossref","first-page":"ofaa634","DOI":"10.1093\/ofid\/ofaa634","article-title":"Low but increasing prevalence of reduced beta-lactam susceptibility among invasive group B Streptococcal isolates, US population-based surveillance, 1998-2018","volume":"8","author":"Kobayashi","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajpath.2022.06.011_bib17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1128\/AAC.01311-13","article-title":"Genomic analyses of DNA transformation and penicillin resistance in Streptococcus pneumoniae clinical isolates","volume":"58","author":"Fani","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajpath.2022.06.011_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1574-6976.2007.00095.x","article-title":"Penicillin-binding proteins\u00a0and beta-lactam resistance","volume":"32","author":"Zapun","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ajpath.2022.06.011_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.meegid.2008.02.001","article-title":"Positive selection in penicillin-binding proteins 1a, 2b, and 2x from Streptococcus pneumoniae and its correlation with amoxicillin resistance development","volume":"8","author":"Stanhope","year":"2008","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ajpath.2022.06.011_bib20","first-page":"e000305","article-title":"Genomic epidemiology of penicillin-non-susceptible Streptococcus pneumoniae","volume":"5","author":"Dew\u00e9","year":"2019","journal-title":"Microb Genom"},{"key":"10.1016\/j.ajpath.2022.06.011_bib21","doi-asserted-by":"crossref","first-page":"e1004547","DOI":"10.1371\/journal.pgen.1004547","article-title":"Comprehensive identification of single nucleotide polymorphisms associated with beta-lactam resistance within pneumococcal mosaic genes","volume":"10","author":"Chewapreecha","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ajpath.2022.06.011_bib22","first-page":"338","article-title":"IDSA updates guideline for managing group A Streptococcal pharyngitis","volume":"88","author":"Randel","year":"2013","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajpath.2022.06.011_bib23","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1093\/cid\/cis629","article-title":"Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America","volume":"55","author":"Shulman","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2022.06.011_bib24","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2020-11-6","article-title":"Paediatrics: how to manage pharyngitis in an era of increasing antimicrobial resistance","volume":"10","author":"Robinson","year":"2021","journal-title":"Drugs Context"},{"key":"10.1016\/j.ajpath.2022.06.011_bib25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jamapediatrics.2014.1582","article-title":"Overprescribing and inappropriate antibiotic selection for children with pharyngitis in the United States, 1997-2010","volume":"168","author":"Dooling","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajpath.2022.06.011_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/cid\/ciz225","article-title":"Changes in US outpatient antibiotic prescriptions from 2011-2016","volume":"70","author":"King","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2022.06.011_bib27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00006454-199407000-00009","article-title":"In\u00a0vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics","volume":"13","author":"Coonan","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajpath.2022.06.011_bib28","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/00006454-199912000-00008","article-title":"Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997","volume":"18","author":"Kaplan","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajpath.2022.06.011_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00006454-199805000-00006","article-title":"Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades","volume":"17","author":"Macris","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajpath.2022.06.011_bib30","doi-asserted-by":"crossref","first-page":"e0021321","DOI":"10.1128\/JCM.00213-21","article-title":"Overview of changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st edition","volume":"59","author":"Humphries","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajpath.2022.06.011_bib31","doi-asserted-by":"crossref","first-page":"e01864-19","DOI":"10.1128\/JCM.01864-19","article-title":"The Clinical and Laboratory Standards Institute Subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes","volume":"58","author":"Weinstein","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajpath.2022.06.011_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cid\/ciz1000","article-title":"Streptococcus pyogenes pbp2x mutation confers reduced susceptibility to beta-lactam antibiotics","volume":"71","author":"Vannice","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2022.06.011_bib33","doi-asserted-by":"crossref","first-page":"e01993-19","DOI":"10.1128\/JCM.01993-19","article-title":"Reduced in\u00a0vitro susceptibility of Streptococcus pyogenes to beta-lactam antibiotics associated with mutations in the pbp2x gene is geographically widespread","volume":"58","author":"Musser","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajpath.2022.06.011_bib34","doi-asserted-by":"crossref","first-page":"e00638-20","DOI":"10.1128\/JCM.00638-20","article-title":"Population genomic molecular epidemiological study of macrolide-resistant Streptococcus pyogenes in Iceland, 1995 to 2016: identification of a large clonal population with a pbp2x mutation conferring reduced in\u00a0vitro beta-lactam susceptibility","volume":"58","author":"Southon","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajpath.2022.06.011_bib35","doi-asserted-by":"crossref","first-page":"e0148221","DOI":"10.1128\/AAC.01482-21","article-title":"Isolation of group A Streptococci with reduced in\u00a0vitro beta-lactam susceptibility harboring amino acid substitutions in penicillin-binding proteins in Japan","volume":"65","author":"Ikeda","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajpath.2022.06.011_bib36","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.ajpath.2020.04.014","article-title":"A single amino acid replacement in penicillin-binding protein 2X in Streptococcus pyogenes significantly increases fitness on subtherapeutic benzylpenicillin treatment in a mouse model of necrotizing myositis","volume":"190","author":"Olsen","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2022.06.011_bib37","doi-asserted-by":"crossref","first-page":"e0361821","DOI":"10.1128\/mbio.03618-21","article-title":"Integrative reverse genetic analysis identifies polymorphisms contributing to decreased antimicrobial agent susceptibility in Streptococcus pyogenes","volume":"13","author":"Beres","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ajpath.2022.06.011_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/cid\/ciz1006","article-title":"Streptococcus pyogenes with reduced susceptibility to beta-lactams: how big an alarm bell?","volume":"71","author":"Hanage","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2022.06.011_bib39","doi-asserted-by":"crossref","first-page":"e00090-20","DOI":"10.1128\/mSphere.00090-20","article-title":"Restricted sequence variation in Streptococcus pyogenes penicillin binding proteins","volume":"5","author":"Hayes","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.ajpath.2022.06.011_bib40","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2147\/IDR.S261975","article-title":"Is there emergence of beta-lactam antibiotic-resistant Streptococcus pyogenes in China?","volume":"13","author":"Yu","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ajpath.2022.06.011_bib41","doi-asserted-by":"crossref","first-page":"707330","DOI":"10.3389\/fmicb.2021.707330","article-title":"Fighting antibiotic resistance in hospital-acquired infections: current state and emerging technologies in disease prevention, diagnostics and therapy","volume":"12","author":"Avershina","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ajpath.2022.06.011_bib42","doi-asserted-by":"crossref","first-page":"e0244063","DOI":"10.1371\/journal.pone.0244063","article-title":"A prospective survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017: comprehensive dynamic of new emergent emm genotypes","volume":"15","author":"Boukthir","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2022.06.011_bib43","doi-asserted-by":"crossref","first-page":"e0023421","DOI":"10.1128\/JB.00234-21","article-title":"Functional insights into the high-molecular-mass penicillin-binding proteins of Streptococcus agalactiae revealed by gene deletion and transposon mutagenesis analysis","volume":"203","author":"Zhu","year":"2021","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ajpath.2022.06.011_bib44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI124994","article-title":"Gene fitness landscape of group A streptococcus during necrotizing myositis","volume":"129","author":"Zhu","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2022.06.011_bib45","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.ajpath.2022.06.011_bib46","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1128\/AAC.00461-08","article-title":"Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics","volume":"52","author":"Dahesh","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajpath.2022.06.011_bib47","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/516375","article-title":"Why have group A streptococci remained susceptible to penicillin? Report on a symposium","volume":"26","author":"Horn","year":"1998","journal-title":"Clin Infect Dis"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944022002000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944022002000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:07:58Z","timestamp":1762081678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944022002000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0002944022002000"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2022.06.011","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Chimeric Penicillin Binding Protein 2X Significantly Decreases in\u00a0Vitro Beta-Lactam Susceptibility and Increases in\u00a0Vivo Fitness of Streptococcus pyogenes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2022.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}